Arteriovenous Fistula Market

 

Arteriovenous Fistula is an abnormal connection between an artery and a vein. Normally, blood flows from the arteries to the capillaries and into the veins. Nutrients and oxygen in the blood travel from capillaries to tissues in the body. With an arteriovenous fistula, blood flows directly from an artery into a vein, bypassing some capillaries, which leads to diminished blood supply in the tissues below the bypassed capillaries. Causes of arteriovenous fistulas include cardiac catheterization, injuries that pierce the skin, being born with an arteriovenous fistula, genetic conditions (such as Osler-Weber-Rendu disease, also known as hereditary hemorrhagic telangiectasia), and/or surgical creation (AV fistula procedure).

DelveInsight’s “Arteriovenous Fistula Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Arteriovenous Fistula, historical and forecasted epidemiology as well as the Arteriovenous Fistula market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Get a Free Sample Copy of the Report at: https://www.delveinsight.com/sample-request/arteriovenous-fistula-market

Arteriovenous Fistula Market Key Facts

  • Another study by Pisoni et al. titled “Vascular access use in Europe and the United States: Results from the DOPPS” found that AVF was used by 80% of EUR countries (France, Germany, Italy, Spain, and the United Kingdom) and 24% of US prevalent patients. 
  • According to a study conducted by Woodside et al. titled “Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study”, wherein 45,087 new AVFs were placed in 39,820 prevalent hemodialysis patients. In addition, only 54.7% of AVFs were used within 4 months of placement, with maturation rates varying considerably across end-stage renal disease (ESRD) networks.
  • As per the United States Renal Data System, in 2016, 80% of patients were using a catheter at hemodialysis (HD) initiation. Out of these, arteriovenous (AV) fistula use at HD initiation rose from 12-17% over the period 2005-2016. The percentage of patients using an AV fistula or with a maturing AV fistula at HD initiation increased from 28.9-33.4% over the same period.

The dynamics of the Arteriovenous fistula market is anticipated to change in the coming years owing to the positive outcomes of the emerging therapies by major key players. The launch of emerging therapies is expected during the forecast period.

Arteriovenous Fistula Companies:

  • Vascular therapies
  • Bard Peripheral Vascular 
  • Intact Vascular
  • Alucent Biomedical
  • And many others. 

Get a Free Sample Copy of the Report at: https://www.delveinsight.com/sample-request/arteriovenous-fistula-market

Key Benefits of Arteriovenous Fistula Market Report:

  • Arteriovenous Fistula market report provides an in-depth analysis of Arteriovenous Fistula Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
  • The Arteriovenous Fistula market report will help in developing business strategies by understanding the Arteriovenous Fistula Market trends & developments, key players, and future market competition that will shape and drive the Arteriovenous Fistula market in the upcoming years.
  • The Arteriovenous Fistula market report covers Arteriovenous Fistula market growth and current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
  • The report provides a detailed assessment of the Arteriovenous Fistula patient population, market drivers & barriers, Unmet Needs, market opportunities, comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Arteriovenous Fistula Therapies:

  • Sirogen
  • Angioplasty with balloon impregnated with paclitaxel
  • Tack Endovascular System
  • And many more.

Get a Free Sample Copy of the Report at: https://www.delveinsight.com/sample-request/arteriovenous-fistula-market

Latest Reports By DelveInsight:

·         Alstrom Syndrome Market

·         Anterior Cruciate Ligament Injuries Market

·         Amblyopia Market

·         Asherman’s Syndrome Market

·         Astigmatism Market

·         Autoimmune Hepatitis Market

·         Autosomal Recessive Congenital Ichthyosis Market

·         Beta Thalassemia Market

·         Biliary Stents Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

 

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more